Ivo Francischetti, MD, PhD
Hematopathology
Highlights
Johns Hopkins Affiliations:
- Johns Hopkins School of Medicine Faculty
About Ivo Francischetti
Professional Titles
- Director, Hematology and Coagulation Laboratory
- Co-Director, Hematopathology Fellowship Program
Primary Academic Title
Assistant Professor of Pathology
Johns Hopkins Physician
Background
Ivo M.B. Francischetti, M.D., Ph.D., is an Assistant Professor of Pathology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include hematology, coagulation, and hematopathology. Dr. Francischetti received his M.D. and Ph.D. from the Federal University of Rio de Janeiro. After moving to the United States, he worked as a staff scientist at the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), where his research focused on vascular biology, vector biology, molecular biology, and cerebral malaria. He completed residency training in anatomic and clinical pathology at the Albert Einstein College of Medicine/Montefiore Medical Center in New York, followed by a fellowship in hematopathology at the National Cancer Institute. Dr. Francischetti joined the faculty at Johns Hopkins in July 2020 and became Director of the Hematology and Coagulation Laboratory in 2021. His research interests include the application of clinical coagulation and hematopathology to the study of bone marrow and hematolymphoid neoplasms. He has published numerous peer-reviewed articles, review papers, and book chapters, and previously served as Chair of an educational subcommittee of the International Society on Thrombosis and Haemostasis (ISTH). He is currently a member of several hematology and pathology professional societies.
Selected Publications
-
Francischetti IM, Toomer V, Zhang Y, Jani J, Siddiqui Z, Brotman DJ, Hooper JE, Kickler TS. Upregulation of pulmonary tissue factor, loss of thrombomodulin and immunothrombosis in SARS-CoV-2 infection. E Clinical Medicine 2021 Sep;39:101069
-
Francischetti IM, Valenzuela JG, Andersen JF, Mather TN, Ribeiro JM. Ixolaris, a novel recombinant tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick, Ixodes scapularis: identification of factor X and factor Xa as scaffolds for the inhibition of factor VIIa/tissue factor complex. Blood. 2002 May 15;99(10):3602-12
-
Obiorah IE, Francischetti IM, Wang H-W, Ahn IE, Wang W, Raffeld M, Kreitman RJ, Wiestner A, Calvo KR. Concurrent chronic lymphocytic leukemia/small lymphocytic lymphoma and hairy cell leukemia: clinical, pathologic and molecular features. Leuk Lymphoma 2020 Aug 5; 1-11
-
Pittaluga S, Francischetti IM, Song JY, Jaffe ES. Chapter 78: Lymphomas. In: Clinical Immunology, 6th Edition. Eds., Robert R Rich et al. Elsevier, 2022.
-
Schechter ME, Andrade BB, He T, Richter GH, Tosh KW, Policicchio BB, Singh A, Raehtz KD, Sheikh V, Ma D, Brocca-Cofano E, Apetrei C, Tracy R, Ribeiro RM, Sher A, Francischetti IMB, Pandrea I, Sereti I. Inflammatory monocytes expressing tissue factor drive SIV and HIV coagulopathy. Sci Transl Med. 2017 Aug 30;9(405)
Locations
- The Johns Hopkins Hospital
- 1800 Orleans Street, Baltimore, MD 21287
- Get Directions
- phone: 410-955-5000
- fax: 410-955-5001
Expertise
Education
- Fellowship: National Institutes of Health, Hematopathology, 2019
- Residency: Montefiore Einstein Medical Center, Pathology - Anatomic & Clinical, 2018
- Graduate School: Universidade Federal do Rio de Janeiro, PhD, 1997
- Medical Education: Universidade Federal do Rio de Janeiro, MD, 1995
Board Certifications
- Hematopathology: American Board of Pathology, 2019
- Anatomic Pathology: American Board of Pathology, 2018
- Clinical Pathology: American Board of Pathology, 2018
Insurance
- Aetna
- CareFirst
- Cigna
- First Health
- Geisinger Health Plan
- HealthSmart/Accel
- Johns Hopkins Health Plans
- MultiPlan
- Pennsylvania's Preferred Health Networks (PPHN)
- Point Comfort Underwriters
- Private Healthcare Systems (PHCS)
- Veteran Affairs Community Care Network (Optum-VACCN)